Explant vs Redo-TAVR After Transcatheter Valve Failure: Mid-Term Outcomes From the EXPLANTORREDO-TAVR International Registry.

Gilbert H L Tang,Syed Zaid,Neal S Kleiman,Sachin S Goel,Shinichi Fukuhara,Mateo Marin-Cuartas,Philipp Kiefer,Mohamed Abdel-Wahab,Ole De Backer,Lars Søndergaard,Shekhar Saha,Christian Hagl,Moritz Wyler von Ballmoos,Oliver Bhadra,Lenard Conradi,Kendra J Grubb,Emily Shih,J Michael DiMaio,Molly Szerlip,Keti Vitanova,Hendrik Ruge,Axel Unbehaun,Jorg Kempfert,Luigi Pirelli,Chad A Kliger, Nicholas Van Mieghem,Thijmen W Hokken,Rik Adrichem,Thomas Modine,Silvia Corona,Lin Wang,George Petrossian,Newell Robinson,David Meier,John G Webb,Anson Cheung,Basel Ramlawi,Howard C Herrmann,Nimesh D Desai,Martin Andreas,Markus Mach,Ron Waksman,Christian C Schults,Hasan Ahmad,Joshua B Goldberg,Arnar Geirsson,John K Forrest,Paolo Denti,Igor Belluschi,Walid Ben-Ali,Anita W Asgar,Maurizio Taramasso,Joshua D Rovin,Marco Di Eusanio,Andrea Colli,Tsuyoshi Kaneko,Tamim N Nazif,Martin B Leon,Vinayak N Bapat,Michael J Mack,Michael J Reardon,Janarthanan Sathananthan

JACC. Cardiovascular interventions（2023）

引用 13|浏览69

暂无评分

摘要

In this first report of the EXPLANTORREDO-TAVR global registry, TAVR-explant had a shorter median time to reintervention, with less structural valve degeneration, more prosthesis-patient mismatch, and similar paravalvular leak rates compared with redo-TAVR. TAVR-explant had higher mortality at 30 days and 1 year, but similar rates on landmark analysis after 30 days.

查看译文

关键词

TAVR explantation,paravalvular leak,prosthesis–patient mismatch,redo-TAVR,structural valve degeneration,surgical aortic valve replacement,transcatheter aortic valve replacement,transcatheter valve failure

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要